drugset / Trial / NCT01729884

Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer

NCT01729884 ↗

NaSingle-groupOpen-labelTreatment

Summary

This phase II trial studies how well vaccine therapy works in treating patients with stage IV hormone receptor positive breast cancer. Vaccines made from peptides may help the body build an effective immune response to kill tumor cells.

Timeline

Start
2012-12
Primary completion
2013-06
Completion
—

Outcome

Outcome not reported

Stopped (Enrollment): “Study ended early due to slow enrollment”

Drugs

EvaluationDrugModalityDoseRoute
Subject HER-2/neu peptide vaccine Vaccine — Other